Department of General Surgery, Yongcheng City People's Hospital, Yongcheng, Henan 476600, P.R. China.
Department of Hepatobiliary Surgery, Chinese PLA General Hospital, Beijing 100853, P.R. China.
Mol Med Rep. 2017 Dec;16(6):9256-9262. doi: 10.3892/mmr.2017.7732. Epub 2017 Oct 5.
Pancreatic cancer is the fourth leading cause of cancer‑associated deaths in Western countries, and ranks sixth among cancer‑associated diseases, with the highest mortality rate in China. Deregulation of micro (miR) RNA may contribute to the occurrence and progression of numerous cancers, including pancreatic cancer. In particular, deregulation of microRNA‑720 (miR‑720) has been reported in various types of human cancer. However, the expression and biological role of miR‑720 in pancreatic cancer remains to be elucidated. The present study aimed to investigate the expression and functional role of miR‑720 in pancreatic cancer and determine the underlying regulatory mechanism. The results demonstrated that miR‑720 was expressed at low levels in pancreatic cancer tissue samples and cell lines. Upregulating miR‑720 suppressed pancreatic cancer cell proliferation and invasion in vitro. Additionally, cyclin D1 (CCND1) was identified as the direct target gene of miR‑720 in pancreatic cancer. Furthermore, CCND1 was significantly upregulated in pancreatic cancer tissues and inversely correlated with miR‑720 expression. Furthermore, CCND1 re‑expression partially abrogated the inhibitory effects of miR‑720 on pancreatic cancer cells. Overall, miR‑720 may act as a tumor suppressor by directly targeting CCND1 in pancreatic cancer.
胰腺癌是西方国家癌症相关死亡的第四大主要原因,在癌症相关疾病中排名第六,中国的死亡率最高。微 RNA(miRNA)的失调可能导致包括胰腺癌在内的许多癌症的发生和进展。特别是,miR-720 的失调已在各种人类癌症中报道。然而,miR-720 在胰腺癌中的表达和生物学作用仍有待阐明。本研究旨在探讨 miR-720 在胰腺癌中的表达和功能作用,并确定其潜在的调节机制。结果表明,miR-720 在胰腺癌组织样本和细胞系中表达水平较低。上调 miR-720 抑制了胰腺癌细胞的体外增殖和侵袭。此外,细胞周期蛋白 D1(CCND1)被鉴定为 miR-720 在胰腺癌中的直接靶基因。此外,CCND1 在胰腺癌组织中显著上调,与 miR-720 的表达呈负相关。此外,CCND1 的重新表达部分消除了 miR-720 对胰腺癌细胞的抑制作用。总体而言,miR-720 可能通过直接靶向 CCND1 在胰腺癌中发挥肿瘤抑制作用。